Latest Health News

Pro Medicus Limited’s U.S. subsidiary has locked in two significant 5-year contract renewals worth a combined minimum of A$40 million, reinforcing its position in the competitive medical imaging market.

Spenda Limited has successfully raised $1.4 million through a private placement, supported by both new and existing sophisticated investors, including key directors. The funds will fuel the company’s commercialisation efforts and strengthen its working capital position.

Tivan Limited has committed up to $1 million over four years to support Indigenous communities through a partnership with the Central Land Council, reinforcing its responsible mining approach in Central Australia.

RLF AgTech’s 2025 Oldbury Wheat Trial reveals a substantial profitability uplift with its Complete Crop Nutrition Program, highlighting a significant opportunity in Australia’s broadacre wheat sector.

Little Green Pharma Ltd (ASX: LGP) has proposed a full acquisition of Cannatrek Ltd via a scheme of arrangement, creating a vertically integrated medicinal cannabis group with pro forma FY26 revenues exceeding AUD 100 million. The scheme, supported by an independent expert, offers liquidity and strategic growth opportunities amid regulatory and market risks.

AKORA Resources has secured a 25-year mining permit for its high-grade Bekisopa iron ore project in Madagascar, marking a pivotal step from exploration to development and unlocking new financing and partnership opportunities.

Island Pharmaceuticals has entered a pivotal research agreement with USAMRIID and the Geneva Foundation to accelerate FDA approval of Galidesivir for Marburg Virus Disease, leveraging top-tier US biodefense expertise.

Rhythm Biosciences has inked a pivotal distribution agreement with UK-based Digistain Limited to introduce its geneType™ genetic test portfolio in Southeast Asia, starting with the Philippines. This marks Rhythm’s first commercial foothold in the region, setting the stage for broader expansion.

Straker Ltd announces a pivotal leadership shift with the appointment of David Sowerby and Indiver Nagpal as Co-CEOs, marking a new era focused on commercial expansion and AI innovation. Founder Grant Straker transitions to a strategic board role to steer the company’s AI future.

Nuchev Limited has transitioned from an agency to a distribution model with H&S Global, aiming to enhance margins and scale growth across key wellness brands.

Control Bionics has secured a key regulatory milestone with its NeuroNode device now eligible for reimbursement under Germany’s statutory health insurance, paving the way for expanded European distribution.

Bougainville Copper Limited reported a preliminary net loss of K16 million for 2025, with no dividend declared. The company faces strategic uncertainty following a shareholder dispute over its preferred mining partner and the passing of its CEO.